Choose Your Country or Region

Palonosetron HCl

Name: Palonosetron HCl
Brand: Selleck Chemicals
SKU: S3050
Rating: 5 (1 reviews)

Synonyms: RS 25259, RS 25259 197

Catalog No.S3050 Purity: 99.99%

Palonosetron HCl (RS 25259, RS 25259 197) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting.

Palonosetron HCl Chemical Structure

CAS: 135729-62-3

Purity & Quality Control

Batch: Purity: 99.99%

99.99

Palonosetron HCl Related Products

Related Targets	5-HT1 5-HT2 5-HT3 5-HT4 5-HT6 5-HT7 5-HT5	Click to Expand
Related Products	Olanzapine Aripiprazole Puerarin Clozapine WAY-100635 Maleate Serotonin (5-HT) HCl Citalopram HBr Prucalopride BRL-15572 Dihydrochloride SB269970 HCl Trazodone Prucalopride Succinate Ketanserin RS-127445 Agomelatine (S20098) Risperidone Pimavanserin tartrate Azacyclonol Tegaserod Maleate Nuciferine Flopropione Vilazodone HCl SB742457 Almotriptan Malate BRL 15572 BRL-54443 Perospirone hydrochloride Alverine Citrate Cyproheptadine hydrochloride sesquihydrate Buspirone HCl Cisapride hydrate Alosetron Hydrochloride Loxapine Succinate Flibanserin Ondansetron Ramosetron Hydrochloride Trazodone HCl SB 271046 hydrochloride Zolmitriptan PRX-08066 Maleic acid Thioridazine hydrochloride Blonanserin Vilazodone	Click to Expand
Related Compound Libraries	FDA-approved Drug Library Natural Product Library Neuronal Signaling Compound Library CNS-Penetrant Compound Library Anti-alzheimer Disease Compound Library	Click to Expand

Signaling Pathway

5-HT Receptor Signaling Pathway

Choose Selective 5-HT Receptor Inhibitors

Biological Activity

Description

Palonosetron HCl (RS 25259, RS 25259 197) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting.

Targets

5-HT3 ^[1]

In vitro
In vitro	Palonosetron is a highly potent, selective, second-generation 5-HT3 receptor antagonist with a 5-HT3 receptor binding affinity that is ∼100-fold higher than other 5-HT3 receptor antagonists (pKi 10.5 compared with 8.91 for granisetron, 8.81 for tropisetron, 8.39 for ondansetron, 7.6 for dolasetron). Palonosetron also has an extended plasma elimination half-life of ∼40 h, significantly longer than others in its class (ondansetron, 4 h; tropisetron, 7.3 h; dolasetron, 7.5 h; ranisetron, 8.9 h).

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT04486157	Completed	Healthy	HK inno.N Corporation	March 18 2021	Phase 1
NCT04466046	Completed	Postoperative Nausea and Vomiting	Daegu Catholic University Medical Center	September 4 2019	--
NCT03148704	Unknown status	Palonosetron	Cttq	March 8 2017	--
NCT00982995	Terminated	Nausea\|Vomiting\|Terminally Ill	University of Michigan Rogel Cancer Center	November 2010	Phase 2
NCT01074697	Completed	Nausea\|Vomiting\|Genital Neoplasms Female	Odense University Hospital\|Helsinn Healthcare SA	April 2010	Phase 3

References

Chemical Information & Solubility

Molecular Weight	332.87	Formula	C₁₉H₂₄N₂O.HCl
CAS No.	135729-62-3	SDF	Download Palonosetron HCl SDF
Smiles	C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5.Cl
Storage (From the date of receipt)	3 years-20°Cpowder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	3 years-20°Cpowder		1 month-20°Cin solvent

In vitro
Batch:

Water : 67 mg/mL

DMSO : Insoluble ( Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : Insoluble

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):